Pharmaceutical companies are among the most willing companies in the world to pay for.

From top to bottom, from Pfizer to Mozambique's Beira pharmaceutical factory, one counts as the other, spending on publicity and marketing, government public relations and legal security, all of which are at the forefront of all industries.

Put simply, the more lucrative and disreputable a company is, the more it will need to spend a lot of extra money to maintain its already collapsed image and protect fragile ecosystems, such as arms dealers, energy companies, or pharmaceutical companies.

On the other hand, the larger the scale of the company, the greater the degree of cross-border and cross-regional, and the more investment resources are needed.

Why is Coca-Cola willing to pay hundreds of thousands of dollars to Yang Rui for an investment that is not in their plan? Because in their marketing plan, it is so common to spend hundreds of thousands of dollars on a meeting and a project, even Coca-Cola in China is willing to spend a lot of cash when it finds a suitable project.

In some cases, such multinationals will pay tens of thousands of dollars to an obscure scholar in exchange for his "advocacy" or simply a speech to a crowd that doesn't care. The cost of first-class airfare and hotel round-trip, plus the cost of lectures, is staggering.

Pharmaceutical companies are even more bold.

When a company spends tens of millions of dollars a year on average for all kinds of litigation, they are more generous in maintaining relationships than the average factory can produce in an annual manner.

Sometimes, pharmaceutical companies can pull hundreds of millions of dollars out of their pockets for a new drug lobbying.

Astra is also one of the world's leading original drug companies, paying countless taxes to the Swedish government every year, and the turnover from selling drugs is often tens of billions of yuan a year.

For pharmaceutical companies at this level, the first point they need to care about is the research and development of drugs and the launch of new drugs.

In fact, the R&D capabilities of large pharmaceutical companies are not necessarily stronger than those of small pharmaceutical companies, and the most accustomed way for them is to buy the patents of small pharmaceutical companies and use their strong marketing capabilities and government relations to promote the drugs.

However, pharmaceutical patents are only one part of the drug research and development process.

To the point of Astra, they not only have to care about what new drugs have come out, but they also have to care about what new drugs we can do now.

What new drugs can be made depends on the development and initiatives of basic medicine.

For example, G protein-coupled receptors are the source of new drugs for a long time in the future, and once 50% of new drugs were made in G protein-coupled receptors.

Astra was naturally unwilling to be left behind, and they grabbed the olive branch handed over by Yang Rui.

Companies like Big Pharma are not afraid of your conditions, especially in Sweden.

Yang Rui is not the first biologist interested in the Nobel Prize, nor will he be the last.

After a simple visit to the pharmaceutical factory that day, without being greeted by Yang Rui or Zhou Yingyao, the Astra official who was in charge of the itinerary and introduction came over and said, "Mr. Yang Rui, I heard that your Chinese embassy is going to hold a dinner. I've already signed up. ”

"Oh, thanks for participating. Yang Rui showed considerable enthusiasm.

"I'll introduce myself again, Pulitzer. I'm from Stockholm. When I was a child, my favorite festival every year was the Nobel Prize ceremony. Pulitzer smiled and said, "At that time, Stockholm was the most lively place, where we drank, laughed, and watched real scientists win awards. ”

Yang Rui nodded slightly.

"There's a saying that even the most lively Swedes don't have the shyest American extroverts, except after drinking. Pulitzer raised the wine glass he held in his hand and said, "Mr. Yang Rui, Astra believes that your research on G protein-coupled receptors and PCR has commendable originality and commendable influence, and you deserve the Nobel Prize." ”

"That's what Astra thinks?"

"Of course. ”

"Thank you very much for your appreciation. Yang Rui couldn't help but look up. That's why he's coming to Sweden, he has to tell people that there are people here who are eligible for the Nobel Prize, and that this person is willing to win the Nobel Prize.

However, Astra was originally the easiest Swedish company to conquer, and their relationship with Jielizenea and their intemperance as a pharmaceutical company determined that they were more willing to support Yang Rui. However, from a stepping stone point of view, Astra is once again significant.

Yang Rui also said with affection: "The attitude of Astra is very important to me, Mr. Pulitzer, you are the first company I have contacted in Sweden, and the first company to give me full support, thank you very much." ”

Pulitzer smiled very Swedely, quickly reined in, and said: "Mr. Yang Rui, I want to make it clear that it cannot be called the full support of Astra Company now, of course we support you very much......"

"Under what conditions will you fully support it?" In the face of such a multinational company, even a Swedish multinational company, Yang Rui does not have to maintain the so-called celebrity demeanor.

A commercial company is a company that pays attention to transactions, and Yang Rui is also a person with capital.

Pulitzer glanced at Yang Rui in surprise and said, "Your approach reminds me of the Americans, oh no, it should be more like the British." ”

"Oh?"

"The British always talk about very important issues in a flat tone. ”

"That's why 007 in the UK is famous. Yang Rui smiled and said, "I think Swedes are always very calm. ”

"It's not so much indifference. Pulitzer changed the subject and said, "Mr. Yang Rui, if Astra fully supports you, what kind of reward can you provide?" ”

"I can give your fellows a month's worth of lessons and answer their questions. Yang Rui said.

Pulitzer was stunned for a moment, couldn't help laughing, and said, "Mr. Yang Rui, you are a person who is good at telling jokes. ”

"Not a joke, Mr. Pulitzer. ”

Pulitzer straightened his face and said: "Mr. Yang Rui, I would rather think it's a joke, Astra is a big pharmaceutical company with many years of tradition and self-confidence, and we are very willing to accept information from the outside world and discuss with researchers from other countries, but ......"

"It only took me two months to make deferiprone made. Yang Rui didn't let him finish, and interrupted: "And 7 active substances have been made, and now it seems that the phase III clinical trial is also going well, and the phase IV clinical trial is even more problematic......

Pulitzer was a little short of words. Although Astra is a large company with tens of billions of dollars in marketing, the original new drugs they can pass every year - in fact, no large company can do it every year, and cruelty is the norm in drug development.

"Think about it. Yang Rui's voice was full of seduction, and said: "I am the researcher who knows G protein-coupled receptors best in the world, although I am a little embarrassed to boast about myself like this, but do you think my positioning is appropriate?"

"I think it's very appropriate. Pulitzer said this sentence strongly, and the thoughts in his mind instantly came out.

The reason why the research on G protein-coupled receptors is called Wang Qi is because its seven-time transmembrane mechanism is so perverted, it affects almost all aspects of the human body, from smell to life support......

In other words, through G protein-coupled receptors, it can affect all aspects of the human body, and the resulting targets are simply innumerable.

And Yang Rui, he is a man holding the royal flag.

Although the news that Yang Rui has completed the second stage of the G protein-coupled receptor has not yet come out, and Pulitzer does not know about it, but his progress in the first stage alone is not yet replicated.

In other words, Yang Rui is the first person in terms of G protein-coupled receptors.

What's even more rare is that he is not a biologist who only knows basic research, he also presided over the development of a new drug.

Such an experience made Pulitzer greedy.

"Full support is a big topic. Pulitzer's expression became serious, and he said, "I don't have the right to decide, but I can report to the CEO." ”

Sweden is the country that advocates flat governance, and many people are qualified to report to the top.

Yang Rui nodded, laughed again, and said, "You don't have to be too nervous, maybe you can arrange time for me to have some in-depth conversations with your researchers, such as in the form of lectures?"

"Would you like that?"

"Of course. ”

"Great, thank you very much. Pulitzer immediately agreed: "I'll make the arrangements right away...... Oh, do you want to give the lecture a name?"

"How about a hands-on lesson for G protein-coupled receptors. In Yang Rui's mind, what came to mind was the image of a salesman who distributed trial clothes.

Please use the search engine to perfectly break the anti-theft chapter, all kinds of you can watch

Remember the mobile version URL: m.